Equine Potomavac + Imrab (Canada)

Rabies Vaccine, Killed Virus

Ehrlichia Risticii Bacterin

PHF-Rabies

DESCRIPTION: Equine Potomavac™ + Imrab^® is a liquid suspension of inactivated rabies virus propagated in a stable cell line, combined with an inactivated suspension of Ehrlichia risticii. Safety and efficacy of this product have been demonstrated in controlled vaccination challenge tests and thorough field evaluations.

INDICATIONS: Equine Potomavac™ + Imrab^® is recommended for the vaccination of healthy horses against disease caused by rabies virus and as an aid in the prevention of Potomac Horse Fever (equine monocytic ehrlichiosis) caused by E. risticii.

DOSAGE: For primary vaccination, aseptically inject 1 mL (1 dose) intramuscularly into healthy horses 3 months of age or older. For E. risticii, revaccinate with 1 dose 3 to 4 weeks later using this product or Equine Potomavac™. Revaccinate annually with a single 1 mL dose.

PRECAUTIONS: Store at 2-7°C (35-45°F). Do not freeze. Use entire contents when first opened. Shake well before using. Contains gentamicin and thimerosal as preservatives. Do not vaccinate within 21 days prior to slaughter. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine. Vaccinating animals whose immune response is compromised by stress, disease, etc. may not produce the desired results.

SOLD TO VETERINARIANS ONLY

For veterinary use only.

Potomavac™ is a trademark and Imrab^® is a registered trademark of MERIAL.

Manufactured By MERIAL INC., Athens, GA 30601 USA

U.S. Vet. Lic. No. 298

1-888-Merial-1 (1-888-637-4251)

Distributed In Canada By MERIAL CANADA, INC., Baie d’Urfé, Qc, H9X 4B6

CPN: 1182018.4